Welcome to CDC stacks | Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease. - 3271 | Emerging Infectious Diseases | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.
  • Published Date:
    1999 Nov-Dec
  • Source:
    Emerg Infect Dis. 5(6):828-831.
Filetype[PDF-94.74 KB]


Details:
No Related Documents.
You May Also Like:
  1. Preventing pneumococcal disease among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Levine, Orin S.; Schwartz, Benjamin; Van Beneden, Chris A.; Whitney, Cynthia G.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.). National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases.. National Immunization Program (Centers for Disease Control and Prevention). Division of Epidemiology and Surveillance..
    Published:
    October 6, 2000
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. RR-9 PMID:11055835:MODS 11055835
    Description:
    In February 2000, a 7-valent pneumococcal polysaccharide-protein conjugate vaccine (Prevnar, marketed by Wyeth Lederle Vaccines) was licensed for use among infants and young children. CDC's Advisory Committee on Immunization Practices (ACIP) recommen...
    File Type:
    Filetype[PDF - 317.21 KB]
  2. Preventing pneumococcal disease among infants and young children : ecommendations of the Advisory Committee on Immunization Practices (ACIP).
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    10/06/2000
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-9):1-35.
    Description:
    In February 2000, a 7-valent pneumococcal polysaccharide-protein conjugate vaccine (Prevnar, marketed by Wyeth Lederle Vaccines) was licensed for use among infants and young children. CDC's Advisory Committee on Immunization Practices (ACIP) recommen...
    Status:
    superseded
    File Type:
    Filetype[PDF - 317.21 KB]
  3. Pneumococcal vaccination practices among private physicians.
    Personal Author:
    Patriarca, Peter A.; Schlech, Walter F.; Hinman, Alan R.; Conn, Judith M.; Gunn, Walter J.;
    Published:
    1982 Sep-Oct
    Source:
    Public Health Rep. 97(5):406-408
    Description:
    It is estimated that less than 10 percent of patients thought to be at high risk of invasive pneumococcal diseases have received 14-valent pneumococcal polysaccharide vaccine. To determine if any of these groups are more likely to be vaccinated than ...
    File Type:
    Filetype[PDF - 410.55 KB]
  4. Fluoroquinolone and Other Antimicrobial Resistance in Invasive Pneumococci, Hong Kong, 1995–2001
    Personal Author:
    Ho, Pak-Leung; Que, Tak-Lun; Chiu, Susan S.; Yung, Raymond W. H.; Ng, Tak-Keung; Tsang, Dominic N.C.; Seto, Wing-Hong; Lau, Yu-Lung;
    Published:
    Jul 2004
    Source:
    Emerg Infect Dis. 10(7):1250-1257.
    Description:
    We determined the susceptibilities of 265 invasive isolates of pneumococci obtained during 1995 to 2001 in Hong Kong to 11 antimicrobial agents and their serotypes. Overall, 62.6% isolates were susceptible to penicillin, 20% were intermediately resis...
    File Type:
    Filetype[PDF - 236.14 KB]
  5. Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Breiman, Robert F.; Butler, Jay C.; Nuorti, J. Pekka;
    Corporate Author:
    Centers for Disease Control (U.S.). Immunization Practices Advisory Committee.. Centers for Disease Control and Prevention (U.S.). National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases..
    Published:
    April 4, 1997
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 46, no. RR-8
    Description:
    " This report updates the last recommendations by the Advisory Committee on Immunization Practices (ACIP) concerning pneumococcal polysaccharide vaccine (MMWR 1989;38:64-8,73-6). ACIP recommends that the vaccine be used more extensively and administe...
    Status:
    superseded
    File Type:
    Filetype[PDF - 287.30 KB]